Demand for cheaper Ozempic options prompts compounding rule review

South Africa is revising its rules on customising medicines, including sought-after GLP-1 treatments for diabetes and weight loss, health regulators said, warning pharmacies not to act as small-scale manufacturers.

— Bizcommunity
Read the full story on Bizcommunity

This story was written and published by Bizcommunity. Business.co.za shows its headline and teaser from the publisher’s RSS feed and links to the original.

What business people are saying

0

No comments yet. Be the first.

More in Business

All →